Keep reading as we share a list of myths about asthma you should ... even if symptoms appear to improve. Myth 6: All asthma medications are addictive Asthma medications, such as inhaled ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

Most companies responded by cutting their drug’s list prices ... the most commonly prescribed pediatric asthma treatments, in particular because the inhaler used to deliver the medication ...

Data from a massive real-world study of asthma patients has suggested that overuse of inhalers is widespread ... the preferred reliever therapy across all asthma severities," she added.

Results A total of 30 793 adults with asthma were included, representing 8.1% (19.38 million) of the US population. From 2011 to 2022, a declining trend in the prevalence of CRN among US adults with ...

The independent guideline committee looked at evidence which showed using the combined inhalers when required led to people suffering fewer severe asthma attacks. Professor Jonathan Benger ...

The carbon footprint of blue inhalers is being compared to a lengthy car trip in advice released to asthma patients as British doctors are told to switch out the sprays for a more effective treatment.

In a “true pivot” in asthma care across the UK, new guidelines urge medics to offer inhalers that both relieve and prevent symptoms to newly diagnosed sufferers who are 12 and over ...

AZ’s Airsupra (albuterol and budesonide) – developed with Avillion – was approved by the FDA last year for as-needed treatment or prevention of asthma ... with all triple-therapy inhalers ...

The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca ...